Cargando…
Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years?
Recently, cervical cancer rates elevation has been noted in women aged 20–39 years in regions with a very high human development index (HDI). The onset of cancer elevation rates is observed in the age range of 25–29 years, which should necessitate effective precancer screening in younger age groups,...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624363/ https://www.ncbi.nlm.nih.gov/pubmed/34829358 http://dx.doi.org/10.3390/diagnostics11112012 |
_version_ | 1784606156073730048 |
---|---|
author | Trzeszcz, Martyna Mazurec, Maciej Jach, Robert Mazurec, Karolina Jach, Zofia Kotkowska-Szeps, Izabela Kania, Magdalena Wantuchowicz, Mariola Prokopyk, Anna Barcikowski, Piotr Przybylski, Marcin Wach, Joanna Halon, Agnieszka |
author_facet | Trzeszcz, Martyna Mazurec, Maciej Jach, Robert Mazurec, Karolina Jach, Zofia Kotkowska-Szeps, Izabela Kania, Magdalena Wantuchowicz, Mariola Prokopyk, Anna Barcikowski, Piotr Przybylski, Marcin Wach, Joanna Halon, Agnieszka |
author_sort | Trzeszcz, Martyna |
collection | PubMed |
description | Recently, cervical cancer rates elevation has been noted in women aged 20–39 years in regions with a very high human development index (HDI). The onset of cancer elevation rates is observed in the age range of 25–29 years, which should necessitate effective precancer screening in younger age groups, including those <25 years. From 30.066 liquid-based screening tests results (n = 30.066), 3849 liquid-based cytology, 1321 high-risk human papillomavirus (HRHPV) and 316 p16/Ki67 performed in women <30 years were selected. Performance characteristics were calculated for three screening models: primary HRHPV with p16/Ki67 triage, primary cytology with reflex HPV and primary cytology alone. Primary HRHPV with p16/Ki67 triage was significantly more sensitive in high-grade squamous intraepithelial lesion quantified with cervical intraepithelial neoplasia grade 2 or worse [HSIL(CIN2+)] detection than cytology with reflex HRHPV and cytology alone (83.3% vs. 70.8%/45.8%) and had significantly higher diagnostic predictive values (PPV:29.4%/21.3%/22.9%; NPV:91.7%/82.9%/82.2%, respectively at CIN2+ threshold). The number of colposcopies per HSIL(CIN2+) detection indices was 3.4, 4.7 and 4.4, respectively. Primary HPV testing in women <30 years with p16/Ki67 triage of HPV-positive cases might be an effective cervical cancer screening strategy for HSIL(CIN2+) detection with superior diagnostic performance when compared with primary cytology-based models. Women <25 years might also benefit from an introduction to a more sensitive screening approach. |
format | Online Article Text |
id | pubmed-8624363 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86243632021-11-27 Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years? Trzeszcz, Martyna Mazurec, Maciej Jach, Robert Mazurec, Karolina Jach, Zofia Kotkowska-Szeps, Izabela Kania, Magdalena Wantuchowicz, Mariola Prokopyk, Anna Barcikowski, Piotr Przybylski, Marcin Wach, Joanna Halon, Agnieszka Diagnostics (Basel) Article Recently, cervical cancer rates elevation has been noted in women aged 20–39 years in regions with a very high human development index (HDI). The onset of cancer elevation rates is observed in the age range of 25–29 years, which should necessitate effective precancer screening in younger age groups, including those <25 years. From 30.066 liquid-based screening tests results (n = 30.066), 3849 liquid-based cytology, 1321 high-risk human papillomavirus (HRHPV) and 316 p16/Ki67 performed in women <30 years were selected. Performance characteristics were calculated for three screening models: primary HRHPV with p16/Ki67 triage, primary cytology with reflex HPV and primary cytology alone. Primary HRHPV with p16/Ki67 triage was significantly more sensitive in high-grade squamous intraepithelial lesion quantified with cervical intraepithelial neoplasia grade 2 or worse [HSIL(CIN2+)] detection than cytology with reflex HRHPV and cytology alone (83.3% vs. 70.8%/45.8%) and had significantly higher diagnostic predictive values (PPV:29.4%/21.3%/22.9%; NPV:91.7%/82.9%/82.2%, respectively at CIN2+ threshold). The number of colposcopies per HSIL(CIN2+) detection indices was 3.4, 4.7 and 4.4, respectively. Primary HPV testing in women <30 years with p16/Ki67 triage of HPV-positive cases might be an effective cervical cancer screening strategy for HSIL(CIN2+) detection with superior diagnostic performance when compared with primary cytology-based models. Women <25 years might also benefit from an introduction to a more sensitive screening approach. MDPI 2021-10-29 /pmc/articles/PMC8624363/ /pubmed/34829358 http://dx.doi.org/10.3390/diagnostics11112012 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Trzeszcz, Martyna Mazurec, Maciej Jach, Robert Mazurec, Karolina Jach, Zofia Kotkowska-Szeps, Izabela Kania, Magdalena Wantuchowicz, Mariola Prokopyk, Anna Barcikowski, Piotr Przybylski, Marcin Wach, Joanna Halon, Agnieszka Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years? |
title | Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years? |
title_full | Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years? |
title_fullStr | Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years? |
title_full_unstemmed | Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years? |
title_short | Is Primary HPV with Secondary p16/Ki67 Dual-Stain an Alternative HSIL-Risk Detection Strategy in Cervical Cancer Screening for Women under 30 Years? |
title_sort | is primary hpv with secondary p16/ki67 dual-stain an alternative hsil-risk detection strategy in cervical cancer screening for women under 30 years? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624363/ https://www.ncbi.nlm.nih.gov/pubmed/34829358 http://dx.doi.org/10.3390/diagnostics11112012 |
work_keys_str_mv | AT trzeszczmartyna isprimaryhpvwithsecondaryp16ki67dualstainanalternativehsilriskdetectionstrategyincervicalcancerscreeningforwomenunder30years AT mazurecmaciej isprimaryhpvwithsecondaryp16ki67dualstainanalternativehsilriskdetectionstrategyincervicalcancerscreeningforwomenunder30years AT jachrobert isprimaryhpvwithsecondaryp16ki67dualstainanalternativehsilriskdetectionstrategyincervicalcancerscreeningforwomenunder30years AT mazureckarolina isprimaryhpvwithsecondaryp16ki67dualstainanalternativehsilriskdetectionstrategyincervicalcancerscreeningforwomenunder30years AT jachzofia isprimaryhpvwithsecondaryp16ki67dualstainanalternativehsilriskdetectionstrategyincervicalcancerscreeningforwomenunder30years AT kotkowskaszepsizabela isprimaryhpvwithsecondaryp16ki67dualstainanalternativehsilriskdetectionstrategyincervicalcancerscreeningforwomenunder30years AT kaniamagdalena isprimaryhpvwithsecondaryp16ki67dualstainanalternativehsilriskdetectionstrategyincervicalcancerscreeningforwomenunder30years AT wantuchowiczmariola isprimaryhpvwithsecondaryp16ki67dualstainanalternativehsilriskdetectionstrategyincervicalcancerscreeningforwomenunder30years AT prokopykanna isprimaryhpvwithsecondaryp16ki67dualstainanalternativehsilriskdetectionstrategyincervicalcancerscreeningforwomenunder30years AT barcikowskipiotr isprimaryhpvwithsecondaryp16ki67dualstainanalternativehsilriskdetectionstrategyincervicalcancerscreeningforwomenunder30years AT przybylskimarcin isprimaryhpvwithsecondaryp16ki67dualstainanalternativehsilriskdetectionstrategyincervicalcancerscreeningforwomenunder30years AT wachjoanna isprimaryhpvwithsecondaryp16ki67dualstainanalternativehsilriskdetectionstrategyincervicalcancerscreeningforwomenunder30years AT halonagnieszka isprimaryhpvwithsecondaryp16ki67dualstainanalternativehsilriskdetectionstrategyincervicalcancerscreeningforwomenunder30years |